LG Chem acquires approval of the first antibody biosimilar ‘Eucept’

Published: 2018-03-20 16:23:35

Updated: 2018-03-20 16:23:35

LG Chem will aim for the Korean antibody biosimilar market.

LG Chem announced on the 16^th that the company acquired approval of ‘Eucept,’ a biosimilar product referencing ‘etanercept,’ an autoimmune disease treatment, from the Ministry of Food and Drug Safety(MFDS).

Eucept, the LG Chem’s first antibody biologic, acquired approval for indications, such as ▲rheumatoid arthritis, ▲psoriatic arth...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.